Enable Injections, maker of manual and connected adhesive wearables for subcutaneously therapeutic delivery, has raised $50 million in a Series B round led by Sanofi, the company announced today. ORI Healthcare Fund, CincyTech, Cincinnati Children's Hospital, Cintrifuse, Ohio Innovation Fund, Cleveland Clinic and other “key private investors” also contributed.
Currently available to pharma and...
Indianapolis-based pharma giant Eli Lilly has announced the company now offers an Android version of its app, called Glucagon, which is designed to help caregivers and providers treat people with diabetes if they fall into an insulin coma.
The app helps the user feel prepared to use Glucagon, which is a prescription drug that must be injected. The Glucagon app allows the user to practice the...
Indianapolis-based pharma giant Eli Lilly is opening a new drug delivery and innovation center in Kendall Square in Cambridge, Massachusetts. Construction will begin immediately, with the center opening by the end of the year for a planned staff of 30 scientists and engineers.
Eli Lilly Senior Director of Global Corporate Communications Edward Sagebiel said one Eli Lilly executive will move to...
